Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
Mar. 31, 2024
Jun. 30, 2023
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 414,745 $ 420,354
Revenues in excess of billings, allowance $ 116,023 $ 1,380,141
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 500,000 500,000
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 14,500,000 14,500,000
Common stock, shares issued 12,344,271 12,284,887
Common stock, shares outstanding 11,405,240 11,345,856
Treasury stock, shares 939,031 939,031